Skip to main content

Table 3 Results of non-parametric bootstrapping and sensitivity analysis

From: (Correcting) misdiagnoses of asthma: a cost effectiveness analysis

Characteristics

Per 100 Patients screened

% Not Asthmatic

28

   2.5% Credible Interval

19

   97.5% Credible Interval

37

% Not Asthmatic and on Daily Medication

20

   2.5% Credible Interval

13

   97.5% Credible Interval

28

Average Cost Savings

$35,141

   2.5% Credible Interval

$4,588

   97.5% Credible Interval

$69,278

*Average cost saving per patient screened is $ 351

 

Sensitivity Analysis

 

25 year time horizon

 

Average Cost Savings

$24,390

   2.5% Credible Interval

$1,181

   97.5% Credible Interval

$47,600

*Average cost saving per patient screened is $ 243

 

GP consult rather than specialist

 

Average Cost Savings

$45,016

   2.5% Credible Interval

$14,463

   97.5% Credible Interval

$79,153

*Average cost saving per patient screened is $ 450

 

As needed 1 to 2 puffs of short-acting bronchodilator per week

 

Average Cost Savings

$29,798

   2.5% Credible Interval

-$3,396

   97.5% Credible Interval

$102,307

*Average cost saving per patient screened is $ 298

 

As needed 4 to 8 puffs of short-acting bronchodilator per week

 

Average Cost Savings

$41,606

   2.5% Credible Interval

$474

   97.5% Credible Interval

$113,843

*Average cost saving per patient screened is $ 416

Â